TrialBMC cancer2022

Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: a retrospective, cohort-controlled trial.

Cunliang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.